Narrative
Full Description
Project narrative
On September 22, 2017, Shandong Weigao Group Medical Polymer Co., Ltd. — a Chinese state-owned single-use medical devices company— entered into a preliminary acquisition agreement with Argon Medical Devices Holdings — a United States-based specialty medical devices, including blood clot removal systems, drainage catheters, and biopsy products, manufacturer— for the company. China Merchants Bank helped support the acquisition. The deal closed in late March or early April, 2018, for $850 million USD. The acquisition was made by an unspecified joint venture between Shandong Weigao (90%) and an anonymous private equity-backed firm (10%) percent which will cover $420 million of the total purchase with debt, according to the Hong Kong stock exchange. By 2023, the Weigao Group signaled that it looked to sell Argon given the state of US-China relations.
Staff comments
1. AidData has assumed that the $420 million USD portion of the total purchase which was financed with debt was provided by China Merchants Bank as industry sources do not indicate the involvement of other financial institutions.